World Drug Report 2005

   

The negative impacts of the illicit drug trade touch every society in the world. This year's World Drug Report estimates that 200 million people, or 5% of the global population age 15-64, have consumed illicit drugs at least once in the last 12 months. The drug trade is pernicious and large. UNODC estimates its retail value at US$ 321bn. It impacts almost every level of human security from individual health, to safety and social welfare. Its consequences are especially devastating for countries with limited resources available to fight against it.

The World Drug Report 2005 provides one of the most comprehensive overviews of illicit drug trends at the international level. In addition, this year it presents the work of UNODC in two new areas of research. Both aim to provide tools to enrich our understanding of an immensely complex situation: an estimate of the financial value of the world drug market, and the preliminary steps towards the creation of an illicit drug index. The analysis of trends, some going back 10 years or more, is presented in Volume 1. Detailed statistics are presented in Volume 2. Taken together these volumes provide the most up to date view of today's illicit drug situation.

World Drug Report 2005

Report

Executive Summary

PressRelease

Presentations

Volume 1: Analysis - Full Report (PDF, 8.75 MB)

French (PDF, 6.76 MB)

Spanish (PDF, 7.26 MB) 

Volume 2: Statistics - Full Report (PDF, 6.72 MB)

French (PDF, 5.72 MB)

Spanish (PDF, 5.39 MB)


 

English (PDF)

English (PDF)

English (PDF)

World Drug Report 2005 by Chapters

Volume 1: Analysis

Volume 2: Statistics

Contents

Preface
Explanatory notes
Executive Summary

Chapter 1.
Trends in World Drug Markets

1.1. The dynamics of the world drug markets
1.2. Opium/Heroin market
1.3. Coca/Cocaine market
1.4. Cannabis market
1.5. Amphetamine-type stimulants market

Chapter 2. Estimating the Value of Illicit Drug Markets

2.1. Background
2.2. Results
2.3. Results of the individual markets
2.4. Conclusions

Chapter 3. HIV/AIDS and Drugs

3.1 Epidemiology of HIV/AIDS and drug use
3.2 Drug use, sexual behaviours and HIV/AIDS
3.3 Conclusions

Chapter 4. Towards the Creation of the an Illicit Drug Index

4.1 Introduction
4.2 Methodology

Contents

Chapter 5. Production

5.1. Opium / Heroin
5.2. Coca / Cocaine
5.3. Cannabis
5.4. Amphetamine-type stimulants
5.5. Other Drugs

Chapter 6. Seizures

6.1 Opiates: Seizures, 1998-2003 6.2 Cocaine: Seizures, 1998-2003 6.3 Cannabis: Seizures, 1998-2003
6.4 Amphetamine-type stimulants: Seizures, 1998-2003

Chapter 7. Prices

7.1. Opiates: Wholesale, street prices and purity levels
7.2. Cocaine: Wholesale, street prices and purity levels
7.3. Cannabis: Wholesale, street prices and purity levels
7.4. ATS: Wholesale, street prices and purity levels

Chapter 8. Consumption

8.1. Annual Prevalence of drug abuse
8.2. Treatment demand
Methodology

 

For Orders from North America, Latin America and the Caribbean, and Asia and the Pacific:

United Nations Publications
Room DC2-0853, Dept. 143
New York, N.Y. 10017
Tel: (800) 253-9646, (212) 963-8302
Fax: (212) 963-3489
E-mail: publications@un.org

For Orders from Europe, Middle East and Affica:

United Nations Publications
Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland
Tel: 41 (22) 917-2614
Fax: 41 (22) 917-0027
E-mail: unpubh@unog.ch

  Previous reports